SCHEMBL20226979

SCHEMBL20226979

CC(C)C1(C)OCCCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20223726 0.77 — —
SCHEMBL21475567 0.74 — —
SCHEMBL18124965 0.72 — —
SCHEMBL21475627 0.71 — —
SCHEMBL14467775 0.68 — —
SCHEMBL20223754 0.67 — —
SCHEMBL15381291 0.65 KMT2A (0.38) —
SCHEMBL22872637 0.64 — —
SCHEMBL19214083 0.64 — —
SCHEMBL19217076 0.64 KMT2A (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10479801-B2 Tetracyclic heterocycle compounds useful as HIV integrase inhibitors MERCK SHARP & DOHME CORP. (US) 2019-11-19 — — US disclosed
US-20180155365-A1 TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-06-07 — — US disclosed
Send feedback